BetterLife Pharma Inc. (CSE:BETR)

Market Cap	12.35M
Revenue (ttm)	n/a
Net Income (ttm)	-4.09M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,000
Average Volume	22,416
Open	0.1100
Previous Close	0.1100
Day's Range	0.1100 - 0.1100
52-Week Range	0.0800 - 0.1950
Beta	1.68
RSI	64.57
Earnings Date	May 30, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benz...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BETR